Cargando…

A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells

New variants in the SARS‐CoV‐2 pandemic are more contagious (Alpha/Delta), evade neutralizing antibodies (Beta), or both (Omicron). This poses a challenge in vaccine development according to WHO. We designed a more universal SARS‐CoV‐2 DNA vaccine containing receptor‐binding domain loops from the hu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Appelberg, Sofia, Ahlén, Gustaf, Yan, Jingyi, Nikouyan, Negin, Weber, Sofie, Larsson, Olivia, Höglund, Urban, Aleman, Soo, Weber, Friedemann, Perlhamre, Emma, Apro, Johanna, Gidlund, Eva‐Karin, Tuvesson, Ola, Salati, Simona, Cadossi, Matteo, Tegel, Hanna, Hober, Sophia, Frelin, Lars, Mirazimi, Ali, Sällberg, Matti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538582/ https://www.ncbi.nlm.nih.gov/pubmed/35986481 http://dx.doi.org/10.15252/emmm.202215821

Ejemplares similares

The SARS-CoV-2 N Protein Is a Good Component in a Vaccine
por: Ahlén, Gustaf, et al.
Publicado: (2020)

A DNA-based vaccine protects against Crimean-Congo hemorrhagic fever virus disease in a Cynomolgus macaque model
por: Hawman, David W., et al.
Publicado: (2020)

Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination
por: Brass, Anette, et al.
Publicado: (2015)

Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responses
por: Holmström, Fredrik, et al.
Publicado: (2016)

A targeted controlled force injection of genetic material in vivo
por: Ahlén, Gustaf, et al.
Publicado: (2016)

Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model
por: Levander, Sepideh, et al.
Publicado: (2018)

A small step closer to the Holy Grail of DNA vaccines: undisputed clinical benefit in humans
por: Frelin, Lars, et al.
Publicado: (2009)

Editorial: HBV—the naked truth?
por: Pasetto, Anna, et al.
Publicado: (2019)

Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis C
por: Weiland, Ola, et al.
Publicado: (2013)

Nucleoside-Modified mRNA Vaccines Protect IFNAR(–/–) Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
por: Appelberg, Sofia, et al.
Publicado: (2022)

Enhanced Seroconversion to West Nile Virus Proteins in Mice by West Nile Kunjin Replicon Virus-like Particles Expressing Glycoproteins from Crimean–Congo Hemorrhagic Fever Virus
por: Tran, Pham-Tue-Hung, et al.
Publicado: (2022)

A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
por: Fournillier, Anne, et al.
Publicado: (2013)

Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis
por: Weber, Friedemann, et al.
Publicado: (2008)

Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections
por: Maravelia, Panagiota, et al.
Publicado: (2020)

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes
por: Ahlén, G, et al.
Publicado: (2009)

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
por: Burm, Rani, et al.
Publicado: (2023)

Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo
por: Bansal, Ruchi, et al.
Publicado: (2015)

ISG15 overexpression compensates the defect of Crimean-Congo hemorrhagic fever virus polymerase bearing a protease-inactive ovarian tumor domain
por: Devignot, Stephanie, et al.
Publicado: (2020)

Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
por: Krishnan, Shuba, et al.
Publicado: (2021)

Hazara virus and Crimean-Congo Hemorrhagic Fever Virus show a different pattern of entry in fully-polarized Caco-2 cell line
por: Monteil, Vanessa, et al.
Publicado: (2020)

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
por: Sandberg, John Tyler, et al.
Publicado: (2021)

The effect of histone deacetylase inhibitors on AHSP expression
por: Okhovat, Mohammad Ali, et al.
Publicado: (2018)

An easy-to-use high-throughput selection system for the discovery of recombinant protein binders from alternative scaffold libraries
por: Möller, Marit, et al.
Publicado: (2023)

Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3
por: Pasetto, Anna, et al.
Publicado: (2012)

Reduction of muscle contraction and pain in electroporation-based treatments: An overview
por: Fusco, Roberta, et al.
Publicado: (2021)

Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
por: Neogi, Ujjwal, et al.
Publicado: (2022)

Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients
por: Lybeck, Charlotte, et al.
Publicado: (2019)

Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-like SH-SY5Y Cells from Oxygen-Glucose Deprivation
por: Vincenzi, Fabrizio, et al.
Publicado: (2020)

Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications
por: Varani, Katia, et al.
Publicado: (2021)

Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
por: Sällberg, Matti, et al.
Publicado: (2020)

Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination
por: Ahlén, G, et al.
Publicado: (2014)

Development of a Multivalent Kunjin Virus Reporter Virus-Like Particle System Inducing Seroconversion for Ebola and West Nile Virus Proteins in Mice
por: Tran, Pham-Tue-Hung, et al.
Publicado: (2020)

Cranberry (Vaccinium macrocarpon) Extract Impairs Nairovirus Infection by Inhibiting the Attachment to Target Cells
por: Mirandola, Mattia, et al.
Publicado: (2021)

The DEVD motif of Crimean-Congo hemorrhagic fever virus nucleoprotein is essential for viral replication in tick cells
por: Salata, Cristiano, et al.
Publicado: (2018)

Low-density lipoprotein receptor–related protein 1 (LRP1) as an auxiliary host factor for RNA viruses
por: Devignot, Stephanie, et al.
Publicado: (2023)

RIG-I-like receptors and negative-strand RNA viruses: RLRly bird catches some worms
por: Weber, Michaela, et al.
Publicado: (2014)

Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
por: Alkharaan, Hassan, et al.
Publicado: (2021)

Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
por: Alkharaan, Hassan, et al.
Publicado: (2022)

Type distribution of human papillomaviruses in ThinPrep cytology samples and HPV16/18 E6 gene variations in FFPE cervical cancer specimens in Fars province, Iran
por: Farhadi, Ali, et al.
Publicado: (2023)

Secretome-Based Screening in Target Discovery
por: Ding, Mei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lapji8br4jl7sts1lg5vjct6u6